Kairos Pharma Ltd

AMEX:KAPA (USA)  
$ 1.70 -0.015 (-0.87%) 11:09 PM EST
At Loss
P/B:
6.56
Market Cap:
$ 21.84M
Enterprise V:
$ 18.77M
Volume:
16.32K
Avg Vol (2M):
384.22K
Trade In:
Volume:
16.32K
At Loss
Avg Vol (2M):
384.22K

Business Description

Description
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
Name Current Vs Industry Vs History
Cash-To-Debt 22.66
Equity-to-Asset 0.67
Debt-to-Equity 0.04
Debt-to-EBITDA -0.06
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -14.9
3-Year EPS without NRI Growth Rate -21.8
3-Year Book Growth Rate -22.5

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 58.37
9-Day RSI 56.01
14-Day RSI 53.71

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.84
Quick Ratio 2.84
Cash Ratio 1.92

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 0.6
Shareholder Yield % 2.06
Name Current Vs Industry Vs History
ROE % -3121.87
ROA % -153.66
ROIC % -247.32
ROCE % -2867.88

Financials (Next Earnings Date:2025-02-28 Est.)

KAPA's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:KAPA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Kairos Pharma Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.25
Beta 0
Volatility % 0
14-Day RSI 53.71
14-Day ATR ($) 0.196721
20-Day SMA ($) 1.608
12-1 Month Momentum % 0
52-Week Range ($) 1.22 - 4
Shares Outstanding (Mil) 12.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kairos Pharma Ltd Filings

Filing Date Document Date Form
No Filing Data

Kairos Pharma Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Kairos Pharma Ltd Frequently Asked Questions

What is Kairos Pharma Ltd(KAPA)'s stock price today?
The current price of KAPA is $1.70. The 52 week high of KAPA is $4.00 and 52 week low is $1.22.
When is next earnings date of Kairos Pharma Ltd(KAPA)?
The next earnings date of Kairos Pharma Ltd(KAPA) is 2025-02-28 Est..
Does Kairos Pharma Ltd(KAPA) pay dividends? If so, how much?
Kairos Pharma Ltd(KAPA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1